Advertisement

Coronavirus inida News

alt
Bharat Biotech's coronavirus vaccine in collaboration with the ICMR has been cleared for the phase 3 of clinical trials. On October 2, the Hyderabad-based vaccine maker had applied to the DCGI seeking permission to conduct Phase 3 trials. The firm said that the study would cover around 28,500 subjects in 19 sites, across 10 states.






Loading...
english news
NEWS ON ONE CLICK